The 3-minute habit linked to longer lives.

Run for the bus.

You know that dash when the bus starts to pull off? Scientists gave it a name… VILPA.

It’s short for quick, hard bursts of effort in plain daily life.

Think of a fast climb up the stairs. Or a brisk walk with full bags of food from the shop.

A big UK team put wrist trackers on 25,241 adults who never worked out. Their average age was 62.

Those who logged three one-minute bursts a day were linked to much longer lives. By the way, that’s three minutes in total.

I spend over $20,000 a year on the kind of deep research hedge funds pay for. Most health claims I read fall apart fast.

This one held up. It had a huge sample and hard data from the wrist in place of guesswork. And it ran in the journal Nature Medicine.

So I tried it for two weeks. I took the stairs hard, three times a day.

By day ten, the climb felt like a warm-up… and I looked forward to the next one.

// Body Hack

The One-Minute Burst

A short, hard push drives your heart and lungs up to top gear. Do it a few times a day and your body starts to build more of that gear.

Here’s the thing. You don’t need a gym, a coach, or a plan in a notebook.

Dose: 3 x 1 min a day · Age: 62 avg · Risk of death: 38 to 40% lower · Heart death: 48 to 49% lower

→ Source: Stamatakis et al., Nature Medicine, 2022

1

Pick a spot: a flight of stairs, a steep hill, or a long hall at work.

2

Go hard for one minute: find a pace where it gets tough to talk.

3

Do three a day: spread them out, with an hour or more in between.

4

Fold it into life: take the stairs, haul the bags, or walk fast to the car.

Meanwhile, a team at McMaster tested a stair plan like this one. Adults who sat most of the day climbed 60 steps, three times a day. Six weeks later, their peak fitness was up.

Climb: 60 steps, 3x a day · Time: 6 weeks · Fitness: up (p = 0.003)

→ Source: Jenkins et al., Appl Physiol Nutr Metab, 2019

If you have a heart condition, check with your doctor first.

// The Frontier

Your body keeps the plans

Three labs are learning to read them back. Here is what they found.

// SuperSight

Each cell in your eye runs on a kind of code that tells it what to be.

With time, that code gets messy. Cells lose track of their jobs.

Life Biosciences, co-founded by Harvard’s David Sinclair, built a gene therapy to tidy it up. It uses three genes, known as OSK, to reset cells to a younger state.

In June, the first person got a dose. The trial covers two optic nerve conditions, one of them glaucoma.

It’s the first time this reset has been tried in a human.

PHASE: 1 · FIRST DOSE: June 2026 · GENES: 3

→ Source: Washington Times, June 2026

// SuperHearing

Some kids are born deaf because of one faulty gene, called OTOF.

Their ears are built fine. The hair cells just can’t pass sound on to the brain.

A Harvard-led team slipped a good copy of the gene into the inner ear. Of 42 people, 90% heard better. After two and a half years, more than half had normal hearing.

“They can hear a whisper,” said Dr. Zheng-Yi Chen.

Meanwhile, the FDA cleared a similar gene therapy in April. It was the first of its kind.

PEOPLE: 42 · HEARD BETTER: 90% · TRACKED: 2.5 years

→ Source: Nature, via Harvard Med, 2026

// SuperStrength

Strength can fade long before muscle size does. A team at the University of Missouri found out why.

The clue sits at the spot where nerve meets muscle. With age, a protein there called NaV1.4 runs low. So the muscle stops hearing the nerve’s call.

In lab animals, the team partly blocked a second protein, ClC-1. The muscle tuned back in… and strength came back with it.

A drug that works this way, from a Danish firm, is in human trials for a nerve disease.

TARGET: ClC-1 · MODEL: lab animals · JOURNAL: JCI

→ Source: Univ. of Missouri, Sept 2026

So what does this mean for you?

Here’s the thing. None of these three is a pill you can buy off a shelf.

But they all point the same way. Your body holds on to the plans… and waits for the right cue.

For muscle, you can send that cue yourself with a heavy weight.

I pay over $20,000 a year for the same deep research tools hedge funds use. That lets me read the trials, not the headlines.

If a claim has no trial behind it, it doesn’t make it in here. Each stat above links to its source, so you can check my work.

And yes, I’m on my own heavy year. Three

Keep Reading

Keep Reading